Assurance Infusion recalls hydromorphone 3mg/ml injection in 20mL syringes due to lack of sterility assurance. Affected lots expire December 2019.
Lack of sterility assurance.
Assurance Infusion is recalling hydromorphone 3mg/ml injection in 20mL syringes because they may not be sterile. This could lead to infections if used improperly.
The syringes may not be sterile, which could cause infections if used. This is a manufacturing issue with the sterility assurance process.
Patients using hydromorphone injections from Assurance Infusion. Healthcare providers administering these injections are most at risk.
Check for the lot numbers 12162019 (expires 12/25/2019) or 12102019 (expires 12/19/2019) on the syringe packaging.
Look for lot numbers 12162019 or 12102019 on the syringe packaging.
Assurance Infusion is recalling hydromorphone 3mg/ml injection in 20mL syringes due to lack of sterility assurance.
Lot numbers 12162019 (expires 12/25/2019) and 12102019 (expires 12/19/2019).
Check the lot number on the syringe packaging; affected lots are 12162019 or 12102019.
We’ve drafted a message you can send Assurance Infusion to request your refund or repair — edit it as you like.
Subject: Recall D-0744-2020 — Assurance Infusion Assurance Infusion Hello, I own a Assurance Infusion that is covered by recall D-0744-2020 from Assurance Infusion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
